欢乐颂第三季,完结小说排行榜

異檸檬酸脫氫酶1(IDH1)單克隆抗體

Monoclonal Antibody to Isocitrate Dehydrogenase 1, Soluble (IDH1)

PICD; IDP; Oxalosuccinate decarboxylase; NADP(+)-specific ICDH; Cytosolic NADP-isocitrate dehydrogenase

酶與激酶

編號MAH839Hu27
物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 所有
- 人
- 小鼠
- 大鼠
- 豚鼠
- 家兔
- 獼猴
- 山羊
- 綿羊
- 馬
- 牛
- 豬
- 雞
- 狗
- 其他物種
- 多物種
- 泛物種
來源單抗制備
宿主小鼠
效價(克隆號)C4
Ig亞型 IgG2a Kappa
純化方式蛋白A + 蛋白G親和純化
標記物無標記物
免疫原 RPH839Hu01-異檸檬酸脫氫酶1(IDH1)重組蛋白
緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
性狀液體
濃度1mg/mL
且適物種-
應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。
下載英文說明書中文說明書
規(guī)格 20μl100μl 200μl 1ml 10ml
價格 ¥ 693 1617 ¥ 1617 ¥ 2310 ¥ 5775 ¥ 23100
欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!

產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)

通過ISO 9001、ISO 13485質(zhì)量體系認證

特異性

該抗體是針對IDH1的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別IDH1。

用法

Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。

贈品

增值服務(wù)

抗體標記定制服務(wù)
Protein-A/G純化柱
 細胞和組織染色液
 抗體陽性對照品
 組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實驗服務(wù)
免疫組織化學(IHC)實驗服務(wù)
免疫細胞化學(ICC)實驗服務(wù)
流式細胞術(shù)(FCM)實驗服務(wù)
免疫沉淀(IP)實驗服務(wù)
免疫熒光(IF)實驗服務(wù)
緩沖液
 DAB顯色試劑盒
 SABC試劑盒
 長臂生物素標記試劑盒
 實時熒光定量PCR實驗服務(wù)

相關(guān)產(chǎn)品

編號	適用物種：Homo sapiens (Human，人)	應用(僅供研究使用，不用于臨床診斷！)
RPH839Hu01	異檸檬酸脫氫酶1(IDH1)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
PAH839Hu01	異檸檬酸脫氫酶1(IDH1)多克隆抗體	WB,IHC
FAH839Hu01	抗異檸檬酸脫氫酶1(IDH1)多克隆抗體	Flow cytometry.
MAH839Hu22	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC
MAH839Hu23	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
MAH839Hu25	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
MAH839Hu27	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
MAH839Hu29	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
MAH839Hu24	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC
MAH839Hu26	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC
MAH839Hu21	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
RAH839Hu21	異檸檬酸脫氫酶1(IDH1)重組抗體	WB; IFC; IHC; IP.
FAH839Hu02	抗異檸檬酸脫氫酶1(IDH1)單克隆抗體	Flow cytometry.
FAH839Hu04	抗異檸檬酸脫氫酶1(IDH1)單克隆抗體	Flow cytometry.
FAH839Hu06	抗異檸檬酸脫氫酶1(IDH1)單克隆抗體	Flow cytometry.
FAH839Hu08	抗異檸檬酸脫氫酶1(IDH1)單克隆抗體	Flow cytometry.
LAH839Hu76	異檸檬酸脫氫酶1(IDH1)單克隆抗體(生物素標記)	WB; IHC; ICC.
IEH839Hu	異檸檬酸脫氫酶1(IDH1)檢測試劑盒(酶聯(lián)免疫吸附試驗法,快捷型)	Enzyme-linked immunosorbent assay for Antigen Detection.
SEH839Hu	異檸檬酸脫氫酶1(IDH1)檢測試劑盒(酶聯(lián)免疫吸附試驗法)	Enzyme-linked immunosorbent assay for Antigen Detection.
SCH839Hu	異檸檬酸脫氫酶1(IDH1)檢測試劑盒(化學發(fā)光免疫分析法)	Chemiluminescent immunoassay for Antigen Detection.
LMH839Hu	異檸檬酸脫氫酶1(IDH1)等多因子檢測試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.
PSH839Hu01	異檸檬酸脫氫酶1(IDH1)抗體對	ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSH839Hu01	異檸檬酸脫氫酶1(IDH1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)	Main materials for "Do It (ELISA Kit) Yourself".

參考文獻

雜志	參考文獻
Molecular & Cellular Proteomics	Identification of IDH1 as a Potential Diagnostic and Prognostic Biomarker for Non-small-cell Lung Cancer by Proteomic Analysis [Mcponline: 008821]
Molecular & Cellular Proteomics	Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis [Pubmed: 22064513]
Clinical Cancer Research	Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer [Pubmed: 24046070]
Onco Targets Ther	The effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cells [PubMed: 25914546]
Oncogene	Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism [Pubmed:29921847]
Molecular Oncology	IDH 2 is a novel diagnostic and prognostic serum biomarker for non‐small‐cell lung cancer [Pubmed:29465809]
Cancers	Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver … [Pubmed: 32443439]
International Journal of Cancer	Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer [Pubmed:35689436]

留言咨詢